Biography

Dr. Abali's research focuses primarily on cancer research, biochemistry, and pharmacology. More specifically, much of her work seeks to understand connections among drug resistance and targeting folate metabolism for cancer treatment. Her research background includes postdoctoral research at the Memorial Sloan Kettering Cancer Center, Columbia University, and Bilkent University. Most recently, Dr. Abali is working on translational regulation of dihydrofolate reductase. She and her team are investigating whether regulating DHFR levels through translational regulation relief can increase BH4 bioavailability and restore eNOS function. The goal is to test promising compounds that are effective in our vitro system in vivo experimental models.

Education Overview

• Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.
• Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus.
• Donec sollicitudin molestie malesuada. Nulla porttitor accumsan tincidunt. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Proin eget tortor risus. Mauris blandit aliquet elit, eget tincidunt nibh pulvinar a.
• Donec sollicitudin molestie malesuada. Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.

Additional education text

this will be an inline link shown in the body of this section

Activities

Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Donec sollicitudin molestie malesuada. Nulla porttitor accumsan tincidunt. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Proin eget tortor risus. Mauris blandit aliquet elit, eget tincidunt nibh pulvinar a. Donec sollicitudin molestie malesuada. Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.

• Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.
• Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus.

this will be an inline link shown in the body of this section 

Publications

• Publication Link 1
• Plublication Link 2

Biography

Dr. Abali's research focuses primarily on cancer research, biochemistry, and pharmacology. More specifically, much of her work seeks to understand connections among drug resistance and targeting folate metabolism for cancer treatment. Her research background includes postdoctoral research at the Memorial Sloan Kettering Cancer Center, Columbia University, and Bilkent University. Most recently, Dr. Abali is working on translational regulation of dihydrofolate reductase. She and her team are investigating whether regulating DHFR levels through translational regulation relief can increase BH4 bioavailability and restore eNOS function. The goal is to test promising compounds that are effective in our vitro system in vivo experimental models.

Education Overview

• Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.
• Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus.
• Donec sollicitudin molestie malesuada. Nulla porttitor accumsan tincidunt. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Proin eget tortor risus. Mauris blandit aliquet elit, eget tincidunt nibh pulvinar a.
• Donec sollicitudin molestie malesuada. Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.

Additional education text

this will be an inline link shown in the body of this section

Activities

Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Donec sollicitudin molestie malesuada. Nulla porttitor accumsan tincidunt. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Proin eget tortor risus. Mauris blandit aliquet elit, eget tincidunt nibh pulvinar a. Donec sollicitudin molestie malesuada. Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.

• Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.
• Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus.

this will be an inline link shown in the body of this section 

Publications

• Publication Link 1
• Plublication Link 2

Biography

Dr. Abali's research focuses primarily on cancer research, biochemistry, and pharmacology. More specifically, much of her work seeks to understand connections among drug resistance and targeting folate metabolism for cancer treatment. Her research background includes postdoctoral research at the Memorial Sloan Kettering Cancer Center, Columbia University, and Bilkent University. Most recently, Dr. Abali is working on translational regulation of dihydrofolate reductase. She and her team are investigating whether regulating DHFR levels through translational regulation relief can increase BH4 bioavailability and restore eNOS function. The goal is to test promising compounds that are effective in our vitro system in vivo experimental models.

Education Overview

• Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.
• Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus.
• Donec sollicitudin molestie malesuada. Nulla porttitor accumsan tincidunt. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Proin eget tortor risus. Mauris blandit aliquet elit, eget tincidunt nibh pulvinar a.
• Donec sollicitudin molestie malesuada. Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.

Additional education text

this will be an inline link shown in the body of this section

Activities

Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Donec sollicitudin molestie malesuada. Nulla porttitor accumsan tincidunt. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Proin eget tortor risus. Mauris blandit aliquet elit, eget tincidunt nibh pulvinar a. Donec sollicitudin molestie malesuada. Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.

• Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.
• Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus.

this will be an inline link shown in the body of this section 

Publications

• Publication Link 1
• Plublication Link 2

Biography

Dr. Abali's research focuses primarily on cancer research, biochemistry, and pharmacology. More specifically, much of her work seeks to understand connections among drug resistance and targeting folate metabolism for cancer treatment. Her research background includes postdoctoral research at the Memorial Sloan Kettering Cancer Center, Columbia University, and Bilkent University. Most recently, Dr. Abali is working on translational regulation of dihydrofolate reductase. She and her team are investigating whether regulating DHFR levels through translational regulation relief can increase BH4 bioavailability and restore eNOS function. The goal is to test promising compounds that are effective in our vitro system in vivo experimental models.

Education Overview

• Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.
• Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus.
• Donec sollicitudin molestie malesuada. Nulla porttitor accumsan tincidunt. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Proin eget tortor risus. Mauris blandit aliquet elit, eget tincidunt nibh pulvinar a.
• Donec sollicitudin molestie malesuada. Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.

Additional education text

this will be an inline link shown in the body of this section

Activities

Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Donec sollicitudin molestie malesuada. Nulla porttitor accumsan tincidunt. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Proin eget tortor risus. Mauris blandit aliquet elit, eget tincidunt nibh pulvinar a. Donec sollicitudin molestie malesuada. Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.

• Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.
• Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus.

this will be an inline link shown in the body of this section 

Publications

• Publication Link 1
• Plublication Link 2

Biography

Dr. Abali's research focuses primarily on cancer research, biochemistry, and pharmacology. More specifically, much of her work seeks to understand connections among drug resistance and targeting folate metabolism for cancer treatment. Her research background includes postdoctoral research at the Memorial Sloan Kettering Cancer Center, Columbia University, and Bilkent University. Most recently, Dr. Abali is working on translational regulation of dihydrofolate reductase. She and her team are investigating whether regulating DHFR levels through translational regulation relief can increase BH4 bioavailability and restore eNOS function. The goal is to test promising compounds that are effective in our vitro system in vivo experimental models.

Education Overview

• Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.
• Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus.
• Donec sollicitudin molestie malesuada. Nulla porttitor accumsan tincidunt. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Proin eget tortor risus. Mauris blandit aliquet elit, eget tincidunt nibh pulvinar a.
• Donec sollicitudin molestie malesuada. Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.

Additional education text

this will be an inline link shown in the body of this section

Activities

Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Donec sollicitudin molestie malesuada. Nulla porttitor accumsan tincidunt. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Proin eget tortor risus. Mauris blandit aliquet elit, eget tincidunt nibh pulvinar a. Donec sollicitudin molestie malesuada. Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.

• Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.
• Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus.

this will be an inline link shown in the body of this section 

Publications

• Publication Link 1
• Plublication Link 2

Biography

Dr. Abali's research focuses primarily on cancer research, biochemistry, and pharmacology. More specifically, much of her work seeks to understand connections among drug resistance and targeting folate metabolism for cancer treatment. Her research background includes postdoctoral research at the Memorial Sloan Kettering Cancer Center, Columbia University, and Bilkent University. Most recently, Dr. Abali is working on translational regulation of dihydrofolate reductase. She and her team are investigating whether regulating DHFR levels through translational regulation relief can increase BH4 bioavailability and restore eNOS function. The goal is to test promising compounds that are effective in our vitro system in vivo experimental models.

Education Overview

• Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.
• Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus.
• Donec sollicitudin molestie malesuada. Nulla porttitor accumsan tincidunt. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Proin eget tortor risus. Mauris blandit aliquet elit, eget tincidunt nibh pulvinar a.
• Donec sollicitudin molestie malesuada. Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.

Additional education text

this will be an inline link shown in the body of this section

Activities

Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Donec sollicitudin molestie malesuada. Nulla porttitor accumsan tincidunt. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Proin eget tortor risus. Mauris blandit aliquet elit, eget tincidunt nibh pulvinar a. Donec sollicitudin molestie malesuada. Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.

• Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.
• Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus.

this will be an inline link shown in the body of this section 

Publications

• Publication Link 1
• Plublication Link 2

Biography

Dr. Abali's research focuses primarily on cancer research, biochemistry, and pharmacology. More specifically, much of her work seeks to understand connections among drug resistance and targeting folate metabolism for cancer treatment. Her research background includes postdoctoral research at the Memorial Sloan Kettering Cancer Center, Columbia University, and Bilkent University. Most recently, Dr. Abali is working on translational regulation of dihydrofolate reductase. She and her team are investigating whether regulating DHFR levels through translational regulation relief can increase BH4 bioavailability and restore eNOS function. The goal is to test promising compounds that are effective in our vitro system in vivo experimental models.

Education Overview

• Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.
• Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus.
• Donec sollicitudin molestie malesuada. Nulla porttitor accumsan tincidunt. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Proin eget tortor risus. Mauris blandit aliquet elit, eget tincidunt nibh pulvinar a.
• Donec sollicitudin molestie malesuada. Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.

Additional education text

this will be an inline link shown in the body of this section

Activities

Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Donec sollicitudin molestie malesuada. Nulla porttitor accumsan tincidunt. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Proin eget tortor risus. Mauris blandit aliquet elit, eget tincidunt nibh pulvinar a. Donec sollicitudin molestie malesuada. Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.

• Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.
• Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus.

this will be an inline link shown in the body of this section 

Publications

• Publication Link 1
• Plublication Link 2

Biography

Dr. Abali's research focuses primarily on cancer research, biochemistry, and pharmacology. More specifically, much of her work seeks to understand connections among drug resistance and targeting folate metabolism for cancer treatment. Her research background includes postdoctoral research at the Memorial Sloan Kettering Cancer Center, Columbia University, and Bilkent University. Most recently, Dr. Abali is working on translational regulation of dihydrofolate reductase. She and her team are investigating whether regulating DHFR levels through translational regulation relief can increase BH4 bioavailability and restore eNOS function. The goal is to test promising compounds that are effective in our vitro system in vivo experimental models.

Education Overview

• Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.
• Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus.
• Donec sollicitudin molestie malesuada. Nulla porttitor accumsan tincidunt. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Proin eget tortor risus. Mauris blandit aliquet elit, eget tincidunt nibh pulvinar a.
• Donec sollicitudin molestie malesuada. Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.

Additional education text

this will be an inline link shown in the body of this section

Activities

Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Donec sollicitudin molestie malesuada. Nulla porttitor accumsan tincidunt. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Proin eget tortor risus. Mauris blandit aliquet elit, eget tincidunt nibh pulvinar a. Donec sollicitudin molestie malesuada. Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.

• Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.
• Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus.

this will be an inline link shown in the body of this section 

Publications

• Publication Link 1
• Plublication Link 2